NL-OMON50131
Completed
Not Applicable
In vitro characterization of the immune response of recovered COVID-19 patients and healthy controls to SARS-CoV-2. - Recovered Covid-19 patients blood sampling
ISA Pharmaceuticals B.V.0 sites14 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Corona
- Sponsor
- ISA Pharmaceuticals B.V.
- Enrollment
- 14
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Inclusion criteria for both recovered COVID\-19 patients and healthy participants
- •1\. Participant must sign the study informed consent form prior to any
- •study\-mandated procedure indicating that he or she understands the purpose,
- •procedures and potential risks, and is willing to participate in the study;
- •2\. Participant is male or female and between 18 and 65 years of age, inclusive,
- •at the time of enrollment;
- •3\. Participant is willing and able to complete the study procedures;
- •4\. Participant has a primary care physician at the time of enrollment;
- •5\. Participant is not taking any immunosuppressive medication or other
- •immunomodulating agents (including investigational drugs) for at least 3 weeks
Exclusion Criteria
- •Exclusion criteria for both recovered COVID\-19 patients and healthy participants
- •1\. Participant with a whole blood donation or loss of \>500 ml within 21 days
- •before study blood sampling;
- •2\. Any known factor, condition, or disease that might interfere with
- •compliance, study conduct or interpretation of the results, as deemed by the
- •investigator.
- •Exclusion criteria for healthy participants only
- •1\. Participant reports a previous positive diagnostic test result for
- •SARS\-CoV\-2 infection (serological testing or viral RNA detection by PCR
- •2\. Participant developed clinically overt symptoms of COVID\-19 following close
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 3
Study of immunity to flu vaccine.CTRI/2021/11/037859Christian Medical College Vellore
Completed
Not Applicable
Investigation of cell mediated immune response induced by varicella vaccinePrevention of herpes zosterJPRN-jRCT1080223477The Research Foundation for Microbial Diseases of Osaka University80
Completed
Not Applicable
Characterization of the immune response in patients with urothelial cell carcinoma of the bladder and during the BCG immunotherapy of bladder cancerC67Malignant neoplasm of bladderDRKS00003700Chirurgische Universitätsklinik, Abteilung für Urologie410
Completed
Not Applicable
A study for evaluating the immune response by ingestion of fermented plant extractHealthy adultJPRN-UMIN000052021EP Mediate Co., Ltd.36
Completed
Not Applicable
A study for evaluating the immune response by ingestion of a fucoidan-containing food in adult males and females : a randomized, double blind, placebo-controlled, parallel-group trialJPRN-UMIN000024995TTC Co., Ltd.60